Radiopharmaceutical drugmaker RayzeBio drew interest from two other large drugmakers before agreeing to a $4.1 billion buyout by Bristol Myers...
Medicine
European authorities are set to rescind the approval of a Duchenne muscular dystrophy drug that’s been on the market there...
Dive Brief: Bristol Myers Squibb’s cell therapy for multiple myeloma, Abecma, should be approved for use in patients whose disease...
Dive Brief: ArriVent Biopharma is the second biotechnology company to go public this year, raising $175 million in an initial...
The Food and Drug Administration this week convened a group of experts to discuss ways to develop new drugs for...
Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a...
An 11-year-old boy who was born deaf can hear after receiving an experimental gene therapy, developer Eli Lilly reported on...
Sanofi on Tuesday said it will acquire San Diego biotechnology company Inhibrx in a complex deal that could be worth...
Dive Brief: The makers of CAR-T cell therapies will need to warn about the risk of new blood cancer, the...
Dive Brief: Coherus Biosciences on Monday said it has agreed to sell its approved biosimilar Cimerli, along with supporting staff,...